SH-PRO extract alleviates benign prostatic hyperplasia via ROS-mediated activation of PARP/caspase 3 and inhibition of FOXO3a/AR/PSA signaling in vitro and in vivo

MLA

Ji Eon, Park, et al. “SH-PRO Extract Alleviates Benign Prostatic Hyperplasia via ROS-Mediated Activation of PARP/Caspase 3 and Inhibition of FOXO3a/AR/PSA Signaling in Vitro and in Vivo.” Phytotherapy Research : PTRREFERENCES, Aug. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........d46b2eea2dbd2b46683938042939c475&authtype=sso&custid=ns315887.

APA

Ji Eon, P., Woo-Cheol, S., Hyo-Jung, L., Dahye, Y., Deok Yong, S., Chi-Hoon, A., Su-Yeon, P., Bum Sang, S., So Jung, P., Kyung Seok, K., Geum Duck, P., Sung-Hoon, K., & Dae Young, L. (2022). SH-PRO extract alleviates benign prostatic hyperplasia via ROS-mediated activation of PARP/caspase 3 and inhibition of FOXO3a/AR/PSA signaling in vitro and in vivo. Phytotherapy Research : PTRREFERENCES.

Chicago

Ji Eon, Park, Shin Woo-Cheol, Lee Hyo-Jung, Yoon Dahye, Sim Deok Yong, Ahn Chi-Hoon, Park Su-Yeon, et al. 2022. “SH-PRO Extract Alleviates Benign Prostatic Hyperplasia via ROS-Mediated Activation of PARP/Caspase 3 and Inhibition of FOXO3a/AR/PSA Signaling in Vitro and in Vivo.” Phytotherapy Research : PTRREFERENCES, August. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........d46b2eea2dbd2b46683938042939c475&authtype=sso&custid=ns315887.